North America organ transplant diagnostics market is projected to grow by 8.1% annually in the forecast period and reach $2,227.2 million by 2031, driven by the growing number of transplantations & prevalence of chronic diseases, the high demand for molecular diagnostic tests, the availability of technologically advanced devices, and the surging investment and expenditure in healthcare and diagnostics.
Highlighted with 31 tables and 58 figures, this 123-page report “North America Organ Transplant Diagnostics Market 2021-2031 by Offering (Instruments, Test Kits & Consumables, Software & Services), Transplant (Solid Organ, Stem Cell, Soft Tissue), Application (Diagnostics, Translational Research), Technology (Molecular Technologies, Serology, Flow Cytometry, Others), End User (Hospitals and Transplant Centers, Reference Laboratories, Academic and Research Institutions, Others), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America organ transplant diagnostics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify North America organ transplant diagnostics market in every aspect of the classification from perspectives of Offering, Transplant, Application, Technology, End User, and Country.
Based on Offering, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Instruments
• Test Kits & Consumables
o Kits & Assays
o Consumables
• Software & Services
Based on Transplant, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Solid Organ Transplant
o Kidney
o Liver
o Heart
o Lung
o Pancreas
o Kidney-Pancreas
o Other Solid Organ Transplants
• Stem Cell Transplant
• Soft Tissue Transplant
By Application, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Diagnostics
o Donor Testing
o Recipient Testing
• Translational Research
By Technology, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Molecular Technologies
o PCR
o Sequencing
o Other Molecular Technologies
• Serology
• Flow Cytometry
• Other Technologies
By End User, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Hospitals and Transplant Centers
• Reference Laboratories
• Academic and Research Institutions
• Other End Users
Geographically, the following national/local markets are fully investigated:
• U.S.
• Canada
• Mexico
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Offering, Transplant and Technology over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Abbott Laboratories Inc.
ARUP Laboratories
BAG Health Care GmbH
Becton Dickinson and Company
bioMérieux S.A.
Bio-Rad Laboratories, Inc.
CareDx, Inc.
Eurofins Scientific
F. Hoffmann-La Roche Ltd.
Illumina, Inc.
Immucor, Inc.
Laboratory Corporation of America Holdings
Novacyt Group
Omixon Ltd.
OPKO Health
QIAGEN N.V.
Quest Diagnostics Incorporated
Thermo Fisher Scientific Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 8
1.1 Industry Definition and Research Scope 8
1.1.1 Industry Definition 8
1.1.2 Research Scope 9
1.2 Research Methodology 12
1.2.1 Overview of Market Research Methodology 12
1.2.2 Market Assumption 13
1.2.3 Secondary Data 13
1.2.4 Primary Data 13
1.2.5 Data Filtration and Model Design 14
1.2.6 Market Size/Share Estimation 15
1.2.7 Research Limitations 16
1.3 Executive Summary 17
2 Market Overview and Dynamics 20
2.1 Market Size and Forecast 20
2.1.1 Impact of COVID-19 on World Economy 21
2.1.2 Impact of COVID-19 on the Market 25
2.2 Major Growth Drivers 27
2.3 Market Restraints and Challenges 33
2.4 Emerging Opportunities and Market Trends 36
2.5 Porter’s Fiver Forces Analysis 40
3 Segmentation of North America Market by Offering 44
3.1 Market Overview by Offering 44
3.2 Instruments 46
3.3 Test Kits & Consumables 48
3.3.1 Kits & Assays 49
3.3.2 Consumables 51
3.4 Software & Services 53
4 Segmentation of North America Market by Transplant 55
4.1 Market Overview by Transplant 55
4.2 Solid Organ Transplant 57
4.2.1 Kidney 59
4.2.2 Liver 60
4.2.3 Heart 61
4.2.4 Lung 62
4.2.5 Pancreas 63
4.2.6 Kidney-Pancreas 64
4.2.7 Other Solid Organ Transplants 65
4.3 Stem Cell Transplant 66
4.4 Soft Tissue Transplant 67
5 Segmentation of North America Market by Application 68
5.1 Market Overview by Application 68
5.2 Diagnostics 70
5.2.1 Donor Testing 71
5.2.2 Recipient Testing 72
5.3 Translational Research 73
6 Segmentation of North America Market by Technology 74
6.1 Market Overview by Technology 74
6.2 Molecular Technologies 76
6.2.1 PCR 78
6.2.2 Sequencing 79
6.2.3 Other Molecular Technologies 80
6.3 Serology 81
6.4 Flow Cytometry 82
6.5 Other Technologies 83
7 Segmentation of North America Market by End User 84
7.1 Market Overview by End User 84
7.2 Hospitals and Transplant Centers 86
7.3 Reference Laboratories 87
7.4 Academic and Research Institutions 88
7.5 Other End Users 89
8 North America Market 2021-2031 by Country 90
8.1 Overview of North America Market 90
8.2 U.S. 93
8.3 Canada 96
8.4 Mexico 98
9 Competitive Landscape 100
9.1 Overview of Key Vendors 100
9.2 New Product Launch, Partnership, Investment, and M&A 103
9.3 Company Profiles 104
Abbott Laboratories Inc. 104
ARUP Laboratories 106
BAG Health Care GmbH 107
Becton Dickinson and Company 108
bioMérieux S.A. 109
Bio-Rad Laboratories, Inc. 110
CareDx, Inc. 111
Eurofins Scientific 112
F. Hoffmann-La Roche Ltd. 113
Illumina, Inc. 114
Immucor, Inc. 115
Laboratory Corporation of America Holdings 116
Novacyt Group 117
Omixon Ltd. 118
OPKO Health 119
QIAGEN N.V. 120
Quest Diagnostics Incorporated 121
Thermo Fisher Scientific Inc. 122
RELATED REPORTS 123
List of Tables:
Table 1. Snapshot of North America Organ Transplant Diagnostics Market in Balanced Perspective, 2021-2031 18
Table 2. World Economic Outlook, 2021-2031 22
Table 3. World Economic Outlook, 2021-2023 23
Table 4. World Health Spending by Region, $ bn, 2013-2020 32
Table 5. Main Product Trends and Market Opportunities in North America Organ Transplant Diagnostics Market 36
Table 6. North America Organ Transplant Diagnostics Market by Offering, 2021-2031, $ mn 44
Table 7. Main Platforms and Key Vendors 47
Table 8. North America Organ Transplant Diagnostics Market: Test Kits & Consumables by Type, 2021-2031, $ mn 48
Table 9. Main Kits & Assays and Key Vendors 50
Table 10. Main Consumables and Key Vendors 52
Table 11. Main Services and Key Vendors 54
Table 12. North America Organ Transplant Diagnostics Market by Transplant, 2021-2031, $ mn 55
Table 13. North America Organ Transplant Diagnostics Market: Solid Organ Transplant by Type, 2021-2031, $ mn 58
Table 14. North America Organ Transplant Diagnostics Market by Application, 2021-2031, $ mn 68
Table 15. North America Organ Transplant Diagnostics Market: Diagnostics by Type, 2021-2031, $ mn 70
Table 16. North America Organ Transplant Diagnostics Market by Technology, 2021-2031, $ mn 74
Table 17. North America Organ Transplant Diagnostics Market: Molecular Technologies by Type, 2021-2031, $ mn 77
Table 18. North America Organ Transplant Diagnostics Market by End User, 2021-2031, $ mn 84
Table 19. North America Organ Transplant Diagnostics Market by Country, 2021-2031, $ mn 91
Table 20. U.S. Organ Transplant Diagnostics Market by Offering, 2021-2031, $ mn 95
Table 21. U.S. Organ Transplant Diagnostics Market by Transplant, 2021-2031, $ mn 95
Table 22. U.S. Organ Transplant Diagnostics Market by Technology, 2021-2031, $ mn 95
Table 23. Canada Organ Transplant Diagnostics Market by Offering, 2021-2031, $ mn 97
Table 24. Canada Organ Transplant Diagnostics Market by Transplant, 2021-2031, $ mn 97
Table 25. Canada Organ Transplant Diagnostics Market by Technology, 2021-2031, $ mn 97
Table 26. Mexico Organ Transplant Diagnostics Market by Offering, 2021-2031, $ mn 99
Table 27. Mexico Organ Transplant Diagnostics Market by Transplant, 2021-2031, $ mn 99
Table 28. Mexico Organ Transplant Diagnostics Market by Technology, 2021-2031, $ mn 99
Table 29. Abbott Laboratories Inc.: Company Snapshot 104
Table 30. Abbott Laboratories Inc.: Business Segmentation 105
Table 31. Abbott Laboratories Inc.: Product Portfolio 105
